FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 117 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 6.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $552,000 | +130.0% | 14,662 | +3.9% | 0.00% | +100.0% |
| Q4 2020 | $240,000 | +344.4% | 14,113 | +1.6% | 0.00% | – |
| Q3 2019 | $54,000 | -36.5% | 13,884 | -1.4% | 0.00% | -100.0% |
| Q2 2019 | $85,000 | -59.5% | 14,076 | -10.4% | 0.00% | 0.0% |
| Q1 2019 | $210,000 | +44.8% | 15,702 | +1.0% | 0.00% | 0.0% |
| Q4 2018 | $145,000 | -44.0% | 15,548 | -16.5% | 0.00% | -50.0% |
| Q3 2018 | $259,000 | -14.5% | 18,612 | -2.9% | 0.00% | 0.0% |
| Q2 2018 | $303,000 | -13.2% | 19,167 | -5.7% | 0.00% | 0.0% |
| Q1 2018 | $349,000 | -18.8% | 20,324 | +3.6% | 0.00% | -33.3% |
| Q4 2017 | $430,000 | -42.0% | 19,623 | +8.1% | 0.00% | -57.1% |
| Q3 2017 | $742,000 | +43.5% | 18,149 | +5.7% | 0.01% | +40.0% |
| Q2 2017 | $517,000 | -23.0% | 17,177 | -7.5% | 0.01% | -28.6% |
| Q1 2017 | $671,000 | -42.1% | 18,562 | -19.7% | 0.01% | -46.2% |
| Q4 2016 | $1,159,000 | +5.6% | 23,123 | +10.5% | 0.01% | -13.3% |
| Q3 2016 | $1,098,000 | +9.4% | 20,918 | -13.9% | 0.02% | +15.4% |
| Q2 2016 | $1,004,000 | +6.8% | 24,290 | +5.0% | 0.01% | 0.0% |
| Q1 2016 | $940,000 | -10.9% | 23,137 | -9.0% | 0.01% | 0.0% |
| Q4 2015 | $1,055,000 | +214.9% | 25,418 | +16.9% | 0.01% | +160.0% |
| Q3 2015 | $335,000 | -41.9% | 21,736 | -6.4% | 0.01% | -37.5% |
| Q2 2015 | $577,000 | +4.7% | 23,217 | -3.7% | 0.01% | +33.3% |
| Q1 2015 | $551,000 | +13.6% | 24,115 | +34.2% | 0.01% | 0.0% |
| Q4 2014 | $485,000 | – | 17,974 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eventide Asset Management | 601,000 | $24,587,000 | 1.39% |
| HealthCor Management, L.P. | 1,010,930 | $41,357,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 86,500 | $3,535,000 | 1.38% |
| PURA VIDA INVESTMENTS, LLC | 75,000 | $3,068,000 | 0.90% |
| BB BIOTECH AG | 777,500 | $31,808,000 | 0.88% |
| AWM Investment Company, Inc. | 100,000 | $4,091,000 | 0.71% |
| Granite Point Capital Management, L.P. | 50,000 | $2,046,000 | 0.43% |
| Rock Springs Capital Management LP | 217,700 | $8,906,000 | 0.41% |
| Crestline Management, LP | 50,919 | $2,083,000 | 0.29% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,432,700 | $99,522,000 | 0.24% |